Part of our dedicated Early Career Researcher (ECR) series, this session featured four ECRs who shared their current work in the field of drug discovery.

Invited speakers:

• Louise Walport, Francis Crick Institute London & Imperial College London - 'Diverse binding to a single interface: De novo cyclic peptides as inhibitors of the BET bromodomains'
  
• Nicolas Bery, Inserm/Université Paul Sabatier/CNRS & Cancer Research Centre of Toulouse (CRCT) - 'Discovery of a potent KRAS macromolecule degrader specifically targeting tumours with mutant KRAS'
  
• Bethan Howells, AstraZeneca - 'DNA-Encoded Library Screening and its Applications in AstraZeneca'
• Deepak Balaji Govindaraj, Council for Scientific and Industrial Research - 'Ovarian Cancer for Precision Medicine'
  

This webinar was chaired by Professor Ian Collins, Head of Chemistry and lead of a medicinal chemistry team at The Institute of Cancer Research, and a key member of the Cancer Research UK Cancer Therapeutics Unit.